Lawton Alison Frances 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed May 22, 2025
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-05-22+12,500→ 12,500 totalExercise: $18.36Exp: 2035-05-22→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.